» Articles » PMID: 33340315

Making, Cloning, and the Expression of Human Insulin Genes in Bacteria: The Path to Humulin

Overview
Journal Endocr Rev
Specialty Endocrinology
Date 2020 Dec 19
PMID 33340315
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In the mid- to late 1970s, recombinant deoxyribonucleic acid methods for cloning and expressing genes in E. coli were under intense development. The important question had become: Can humans design and chemically synthesize novel genes that function in bacteria? This question was answered in 1978 and in 1979 with the successful expression in E. coli of 2 mammalian hormones, first somatostatin and then human insulin. The successful production of human insulin in bacteria provided, for the first time, a practical, scalable source of human insulin and resulted in the approval, in 1982, of human insulin for the treatment of diabetics. In this short review, I give my personal view of how the making, cloning, and expressing of human insulin genes was accomplished by a team of scientists led by Keiichi Itakura, Herbert W. Boyer, and myself.

Citing Articles

Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery.

Tenchov R, Hughes K, Ganesan M, Iyer K, Ralhan K, Lotti Diaz L ACS Nano. 2025; 19(4):4011-4038.

PMID: 39823199 PMC: 11803921. DOI: 10.1021/acsnano.4c09566.


Frederick G Banting (1891-1941): A Pioneer in Diabetes Treatment.

Sharma Y, Kannan A, Lee J, Coffman F, Mittal R Cureus. 2024; 16(11):e73806.

PMID: 39691108 PMC: 11650121. DOI: 10.7759/cureus.73806.


Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry.

Rahban M, Ahmad F, Piatyszek M, Haertle T, Saso L, Saboury A RSC Adv. 2023; 13(51):35947-35963.

PMID: 38090079 PMC: 10711991. DOI: 10.1039/d3ra06476j.


Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies.

Nkonge K, Nkonge D, Nkonge T Diabetes Ther. 2023; 14(11):1801-1831.

PMID: 37736787 PMC: 10570256. DOI: 10.1007/s13300-023-01468-4.


Amplifying gene expression with RNA-targeted therapeutics.

Khorkova O, Stahl J, Joji A, Volmar C, Wahlestedt C Nat Rev Drug Discov. 2023; 22(7):539-561.

PMID: 37253858 PMC: 10227815. DOI: 10.1038/s41573-023-00704-7.


References
1.
Drew H, Wing R, Takano T, Broka C, Tanaka S, Itakura K . Structure of a B-DNA dodecamer: conformation and dynamics. Proc Natl Acad Sci U S A. 1981; 78(4):2179-83. PMC: 319307. DOI: 10.1073/pnas.78.4.2179. View

2.
Sures I, Goeddel D, Gray A, Ullrich A . Nucleotide sequence of human preproinsulin complementary DNA. Science. 1980; 208(4439):57-9. DOI: 10.1126/science.6927840. View

3.
Cohen S, Chang A, Boyer H, Helling R . Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A. 1973; 70(11):3240-4. PMC: 427208. DOI: 10.1073/pnas.70.11.3240. View

4.
Ullrich A, Shine J, Chirgwin J, Pictet R, Tischer E, Rutter W . Rat insulin genes: construction of plasmids containing the coding sequences. Science. 1977; 196(4296):1313-9. DOI: 10.1126/science.325648. View

5.
Itakura K, Katagiri N, Narang S, Bahl C, Marians K, Wu R . Chemical synthesis and sequence studies of deoxyribooligonucleotides which constitute the duplex sequence of the lactose operator of Escherichia coli. J Biol Chem. 1975; 250(12):4592-600. View